Evidence map›Paper›PMID 39370272›Full record

ArticleFukushima journal of medical science2024

The utility of MRI for the preoperative differential diagnosis of uterine sarcoma and leiomyoma: a single-center study.

Hiroyuki Yazawa, Riho Yazawa, Kazuki Anjo, Akari Inazuki, Manabu Kikuta

Abstract read
In one paragraph

Article in Fukushima journal of medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroyuki YazawaDepartment of Obstetrics and Gynecology, Fukushima Red Cross Hospital.
Riho YazawaDepartment of Obstetrics and Gynecology, Fukushima Red Cross Hospital.
Kazuki AnjoJunior Resident, Fukushima Red Cross Hospital.
Akari InazukiJunior Resident, Fukushima Red Cross Hospital.
Manabu KikutaDepartment of Radiology, Fukushima Red Cross Hospital.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although uterine sarcoma is a rare disease, its prognosis is extremely poor;thus, it is important to differentiate it from uterine leiomyoma. In this retrospective study, we examined the association between preoperative MRI findings and postoperative pathology results in 170 patients with uterine tumors who underwent preoperative MRI examination at Fukushima Red Cross Hospital. In 4 cases of sarcoma / smooth muscle tumor of unknown malignant potential (STUMP), abnormal findings were found at a high frequency with T1-weighted imaging (T1WI) (75%), T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast enhancement (CE) (100%). In cases of ordinary leiomyoma, on the other hand, abnormal findings were less frequent. The rates of high DWI signal intensity for degenerated and cellular leiomyoma were 31% and 64%, respectively, and the CE-positive rates were 31% and 57%, respectively. Apparent Diffusion Coefficient (ADC) values appeared to be useful in differentiating degenerated leiomyoma from sarcoma. The relatively characteristic findings of uterine sarcoma on MRI images may overlap with those of degenerated leiomyoma and cellular leiomyoma, making it difficult to diagnose sarcoma on imaging alone. However, findings that distinguish sarcoma from ordinary, degenerated, and cellular leiomyoma cases are worthy of attention, to avoid overlooking sarcoma.

Indexed as

LeiomyomaMagnetic Resonance ImagingSarcomaUterine NeoplasmsAdultAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMiddle AgedRetrospective Studiescellular leiomyomadegenerated leiomyomaleiomyomaMRI findingsuterine sarcoma

Identifiers

PMID39370272
PMCPMC11625851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.